Skip to main content
SpringerLink
Log in

Optimization of Treatment Outcomes for Assisted Reproductive Technologies

  • Chapter
  • First Online:
Organization and Management of IVF Units

  • 1080 Accesses

Abstract

The maximization of treatment outcomes is of the highest priority in the realm of Assisted Reproductive Technologies (ART). Couples and fertility centers have high expectations for successful in vitro fertilization (IVF) cycles. It is of paramount importance to preemptively identify and subsequently treat or correct any potential factors that may adversely affect the IVF cycle. In addition, in cases of recurrent implantation failure (RIF) or the downstream recurrent pregnancy loss (RPL), when couples have undergone a certain number of IVF cycles without establishing a potentially successful pregnancy, an understanding of the potential etiologies, evaluation, and whether or not possible treatment adjuncts are efficacious is important in terms of determining whether or not further troubleshooting is warranted. Clinical testing for the couple provides opportunities for troubleshooting prior to proceeding with the IVF cycle and includes a myriad of diagnostic tests which may lead to therapeutic management if any tests are out of normal range. Furthermore, various techniques within the embryology laboratory may optimize ART outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–14.

    Article  CAS  PubMed  Google Scholar 

  2. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17:46–54.

    Article  CAS  PubMed  Google Scholar 

  3. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, Laven JS, de Jong FH, Te Velde ER, Fauser BC, et al. Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab. 2011;96:2532–253.

    Article  CAS  PubMed  Google Scholar 

  4. Bhide P, Gudi A, Shah A, Timms P, Grayson K, Homburg R. Anti-Müllerian hormone as a predictor of pregnancy following IVF. Reprod Biomed Online. 2013;26(3):247–52. doi:10.1016/j.rbmo.2012.11.018. Epub 2012 Dec 8.

    Article  CAS  PubMed  Google Scholar 

  5. Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, Eijkemans MJ, Mol BW, Broekmans FJ. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update. 2013;19:26–36.

    Article  PubMed  Google Scholar 

  6. Reichman DE, Goldschlag D, Rosenwaks Z. Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome. Fertil Steril. 2014;101(4):1012–8.e1. doi:10.1016/j.fertnstert.2013.12.039. Epub 2014 Feb 1.

    Article  CAS  PubMed  Google Scholar 

  7. Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study. Fertil Steril. 2013;100(2):438–44. doi:10.1016/j.fertnstert.2013.03.031. Epub 2013 Apr 16.

    Article  CAS  PubMed  Google Scholar 

  8. Tsoumpou I, Kyrgiou M, Gelbaya TA, Nardo LG. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril. 2009;92(1):75–87. doi:10.1016/j.fertnstert.2008.05.049. Epub 2008 Aug 9.

    Article  PubMed  Google Scholar 

  9. Benschop L, Farquhar C, van der Poel N, Heineman MJ. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev. 2010;11, CD008571. doi:10.1002/14651858.CD008571.pub2.

    PubMed  Google Scholar 

  10. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531–8. doi:10.1016/j.fertnstert.2012.08.009. Epub 2012 Sep 10. Review.

    Article  CAS  PubMed  Google Scholar 

  11. Uncu G, Kasapoglu I, Ozerkan K, Seyhan A, Oral Yilmaztepe A, Ata B. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve. Hum Reprod. 2013;28(8):2140–5. doi:10.1093/humrep/det123. Epub 2013 Apr 26.

    Article  CAS  PubMed  Google Scholar 

  12. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496–501. doi:10.1093/humrep/den398. Epub 2008 Dec 4.

    Article  PubMed  Google Scholar 

  13. Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T, Bayasula B, Nakamura T, Manabe S, Kikkawa F. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod. 2011;26(4):904–10. doi:10.1093/humrep/der006. Epub 2011 Feb 2.

    Article  CAS  PubMed  Google Scholar 

  14. Strandell A, Lindhard A, Waldenström U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod. 1999;14(11):2762–9.

    Article  CAS  PubMed  Google Scholar 

  15. Wainer R, Camus E, Camier B, Martin C, Vasseur C, Merlet F. Does hydrosalpinx reduce the pregnancy rate after in vitro fertilization? Fertil Steril. 1997;68(6):1022–6.

    Article  CAS  PubMed  Google Scholar 

  16. Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, Philippe HJ. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod. 1999;14(5):1243–9.

    Article  CAS  PubMed  Google Scholar 

  17. Sachdev R, Kemmann E, Bohrer MK, el-Danasouri I. Detrimental effect of hydrosalpinx fluid on the development and blastulation of mouse embryos in vitro. Fertil Steril. 1997;68(3):531–3.

    Article  CAS  PubMed  Google Scholar 

  18. Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE, Lessey BA. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod. 1997;12(7):1393–8.

    Article  CAS  PubMed  Google Scholar 

  19. Daftary GS, Kayisli U, Seli E, Bukulmez O, Arici A, Taylor HS. Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx. Fertil Steril. 2007;87(2):367–72. Epub 2006 Dec 14.

    Article  CAS  PubMed  Google Scholar 

  20. Strandell A. Treatment of hydrosalpinx in the patient undergoing assisted reproduction. Curr Opin Obstet Gynecol. 2007;19(4):360–5. Review.

    Article  PubMed  Google Scholar 

  21. Strandell A, Lindhard A. Hydrosalpinx and ART. Salpingectomy prior to IVF can be recommended to a well-defined subgroup of patients. Hum Reprod. 2000;15(10):2072–4.

    Article  CAS  PubMed  Google Scholar 

  22. Johnson N, van Voorst S, Sowter MC, Strandell A, Mol BW. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev. 2010;1, CD002125. doi:10.1002/14651858.CD002125.pub3. Review.

    PubMed  Google Scholar 

  23. Kontoravdis A, Makrakis E, Pantos K, Botsis D, Deligeoroglou E, Creatsas G. Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinx. Fertil Steril. 2006;86(6):1642–9. Epub 2006 Oct 25.

    Article  PubMed  Google Scholar 

  24. Bildirici I, Bukulmez O, Ensari A, Yarali H, Gurgan T. A prospective evaluation of the effect of salpingectomy on endometrial receptivity in cases of women with communicating hydrosalpinges. Hum Reprod. 2001;16(11):2422–6.

    CAS  PubMed  Google Scholar 

  25. Matorras R, Rabanal A, Prieto B, Diez S, Brouard I, Mendoza R, Exposito A. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol. 2013;169(1):54–9. doi:10.1016/j.ejogrb.2013.02.008. Epub 2013 Apr 2.

    Article  PubMed  Google Scholar 

  26. Sonigo C, Collinet P, Rubod C, Catteau-Jonard S. Current position of Essure(®) micro-insert in the management of hydrosalpinges before in vitro fertilization [article in French]. Gynecol Obstet Fertil. 2013;41(2):133–8. doi:10.1016/j.gyobfe.2012.12.010. Epub 2013 Jan 30.

    Article  CAS  PubMed  Google Scholar 

  27. Arora P, Arora RS, Cahill D. Essure(®) for management of hydrosalpinx prior to in vitro fertilisation-a systematic review and pooled analysis. BJOG. 2014;121(5):527–36. doi:10.1111/1471-0528.12533. Epub 2014 Jan 3.

    Article  CAS  PubMed  Google Scholar 

  28. Legendre G, Gallot V, Levaillant JM, Capmas P, Fernandez H. Adiana(®) hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization: a case report [article in French]. J Gynecol Obstet Biol Reprod (Paris). 2013;42(4):401–4. doi:10.1016/j.jgyn.2013.03.008. Epub 2013 Apr 15.

    Article  CAS  Google Scholar 

  29. Fatemi HM, Kasius JC, Timmermans A, van Disseldorp J, Fauser BC, Devroey P, Broekmans FJ. Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization. Hum Reprod. 2010;25(8):1959–65. doi:10.1093/humrep/deq150. Epub 2010 Jun 22.

    Article  CAS  PubMed  Google Scholar 

  30. Karayalcin R, Ozcan S, Moraloglu O, Ozyer S, Mollamahmutoglu L, Batıoglu S. Results of 2500 office-based diagnostic hysteroscopies before IVF. Reprod Biomed Online. 2010;20(5):689–93. doi:10.1016/j.rbmo.2009.12.030. Epub 2010 Feb 1.

    Article  PubMed  Google Scholar 

  31. Pundir J, Pundir V, Omanwa K, Khalaf Y, El-Toukhy T. Hysteroscopy prior to the first IVF cycle: a systematic review and meta-analysis. Reprod Biomed Online. 2014;28(2):151–61. doi:10.1016/j.rbmo.2013.09.025. Epub 2013 Oct 5.

    Article  PubMed  Google Scholar 

  32. Cenksoy P, Ficicioglu C, Yıldırım G, Yesiladali M. Hysteroscopic findings in women with recurrent IVF failures and the effect of correction of hysteroscopic findings on subsequent pregnancy rates. Arch Gynecol Obstet. 2013;287(2):357–60. doi:10.1007/s00404-012-2627-5. Epub 2012 Nov 27.

    Article  PubMed  Google Scholar 

  33. Demirol A, Gurgan T. Effect of treatment of intrauterine pathologies with office hysteroscopy in patients with recurrent IVF failure. Reprod Biomed Online. 2004;8(5):590–4.

    Article  PubMed  Google Scholar 

  34. Rama Raju GA, Shashi Kumari G, Krishna KM, Prakash GJ, Madan K. Assessment of uterine cavity by hysteroscopy in assisted reproduction programme and its influence on pregnancy outcome. Arch Gynecol Obstet. 2006;274(3):160–4. Epub 2006 May 10.

    Article  CAS  PubMed  Google Scholar 

  35. Bosteels J, Weyers S, Puttemans P, Panayotidis C, Van Herendael B, Gomel V, Mol BW, Mathieu C, D’Hooghe T. The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review. Hum Reprod Update. 2010;16(1):1–11. doi:10.1093/humupd/dmp033.Epub. Review.

    Article  PubMed  Google Scholar 

  36. Makrakis E, Pantos K. The outcomes of hysteroscopy in women with implantation failures after in-vitro fertilization: findings and effect on subsequent pregnancy rates. Curr Opin Obstet Gynecol. 2010;22(4):339–43. doi:10.1097/GCO.0b013e32833beaa3.

    PubMed  Google Scholar 

  37. El-Toukhy T, Campo R, Sunkara SK, Khalaf Y, Coomarasamy A. A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure: Trial of Outpatient Hysteroscopy—[TROPHY] in IVF. Reprod Health. 2009;6:20. doi:10.1186/1742-4755-6-20.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Karayalçin R, Ozyer S, Ozcan S, Uzunlar O, Gürlek B, Moraloğlu O, Batioğlu S. Office hysteroscopy improves pregnancy rates following IVF. Reprod Biomed Online. 2012;25(3):261–6. doi:10.1016/j.rbmo.2012.05.013. Epub 2012 Jun 16.

    Article  PubMed  Google Scholar 

  39. Hosseini MA, Ebrahimi N, Mahdavi A, Aleyasin A, Safdarian L, Fallahi P, Esfahani F. Hysteroscopy in patients with repeated implantation failure improves the outcome of assisted reproductive technology in fresh and frozen cycles. J Obstet Gynaecol Res. 2014;40(5):1324–30. doi:10.1111/jog.12315. Epub 2014 Mar 10.

    Article  PubMed  Google Scholar 

  40. Doldi N, Persico P, Di Sebastiano F, Marsiglio E, De Santis L, Rabellotti E, Fusi F, Brigante C, Ferrari A. Pathologic findings in hysteroscopy before in vitro fertilization-embryo transfer (IVF-ET). Gynecol Endocrinol. 2005;21(4):235–7.

    Article  PubMed  Google Scholar 

  41. Isikoglu M, Berkkanoglu M, Senturk Z, Coetzee K, Ozgur K. Endometrial polyps smaller than 1.5 cm do not affect ICSI outcome. Reprod Biomed Online. 2006;12(2):199–204.

    Article  CAS  PubMed  Google Scholar 

  42. Lass A, Williams G, Abusheikha N, Brinsden P. The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles. J Assist Reprod Genet. 1999;16(8):410–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Tiras B, Korucuoglu U, Polat M, Zeyneloglu HB, Saltik A, Yarali H. Management of endometrial polyps diagnosed before or during ICSI cycles. Reprod Biomed Online. 2012;24(1):123–8. doi:10.1016/j.rbmo.2011.09.002. Epub 2011 Sep 16.

    Article  PubMed  Google Scholar 

  44. Eryilmaz OG, Gulerman C, Sarikaya E, Yesilyurt H, Karsli F, Cicek N. Appropriate interval between endometrial polyp resection and the proceeding IVF start. Arch Gynecol Obstet. 2012;285(6):1753–7. doi:10.1007/s00404-012-2238-1.

    Article  PubMed  Google Scholar 

  45. Madani T, Ghaffari F, Kiani K, Hosseini F. Hysteroscopic polypectomy without cycle cancellation in IVF cycles. Reprod Biomed Online. 2009;18(3):412–5.

    Article  PubMed  Google Scholar 

  46. Bernard G, Darai E, Poncelet C, Benifla JL, Madelenat P. Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol. 2000;88(1):85–90.

    Article  CAS  PubMed  Google Scholar 

  47. Bozdag G, Esinler I, Boynukalin K, Aksu T, Gunalp S, Gurgan T. Single intramural leiomyoma with normal hysteroscopic findings does not affect ICSI-embryo transfer outcome. Reprod Biomed Online. 2009;19(2):276–80.

    Article  PubMed  Google Scholar 

  48. Hart R, Khalaf Y, Yeong CT, Seed P, Taylor A, Braude P. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod. 2001;16(11):2411–7.

    CAS  PubMed  Google Scholar 

  49. Somigliana E, De Benedictis S, Vercellini P, Nicolosi AE, Benaglia L, Scarduelli C, Ragni G, Fedele L. Fibroids not encroaching the endometrial cavity and IVF success rate: a prospective study. Hum Reprod. 2011;26(4):834–9. doi:10.1093/humrep/der015. Epub 2011 Feb 11.

    Article  PubMed  Google Scholar 

  50. Oliveira FG, Abdelmassih VG, Diamond MP, Dozortsev D, Melo NR, Abdelmassih R. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril. 2004;81(3):582–7.

    Article  PubMed  Google Scholar 

  51. Yan L, Ding L, Li C, Wang Y, Tang R, Chen ZJ. Effect of fibroids not distorting the endometrial cavity on the outcome of in vitro fertilization treatment: a retrospective cohort study. Fertil Steril. 2014;101(3):716–21. doi:10.1016/j.fertnstert.2013.11.023. Epub 2014 Jan 11.

    Article  PubMed  Google Scholar 

  52. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod. 2010;25(2):418–29. doi:10.1093/humrep/dep396. Epub 2009 Nov 12. Review.

    Article  PubMed  Google Scholar 

  53. Tomaževič T, Ban-Frangež H, Virant-Klun I, Verdenik I, Požlep B, Vrtačnik-Bokal E. Septate, subseptate and arcuate uterus decrease pregnancy and live birth rates in IVF/ICSI. Reprod Biomed Online. 2010;21(5):700–5. doi:10.1016/j.rbmo.2010.06.028. Epub 2010 Jun 25.

    Article  PubMed  Google Scholar 

  54. Ban-Frangez H, Tomazevic T, Virant-Klun I, Verdenik I, Ribic-Pucelj M, Bokal EV. The outcome of singleton pregnancies after IVF/ICSI in women before and after hysteroscopic resection of a uterine septum compared to normal controls. Eur J Obstet Gynecol Reprod Biol. 2009;146(2):184–7. doi:10.1016/j.ejogrb.2008.04.010. Epub 2008 Jun 3.

    Article  CAS  PubMed  Google Scholar 

  55. Ozgur K, Isikoglu M, Donmez L, Oehninger S. Is hysteroscopic correction of an incomplete uterine septum justified prior to IVF? Reprod Biomed Online. 2007;14(3):335–40.

    Article  PubMed  Google Scholar 

  56. Granot I, Gnainsky Y, Dekel N. Endometrial inflammation and effect on implantation improvement and pregnancy outcome. Reproduction. 2012;144(6):661–8. doi:10.1530/REP-12-0217. Epub 2012 Oct 1. Review.

    Article  CAS  PubMed  Google Scholar 

  57. Siristatidis C, Vrachnis N, Vogiatzi P, Chrelias C, Retamar AQ, Bettocchi S, Glujovsky D. Potential pathophysiological mechanisms of the beneficial role of endometrial injury in in vitro fertilization outcome. Reprod Sci. 2014;21(8):955–65. Epub ahead of print.

    Article  PubMed  Google Scholar 

  58. Potdar N, Gelbaya T, Nardo LG. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod Biomed Online. 2012;25(6):561–71. doi:10.1016/j.rbmo.2012.08.005. Epub 2012 Sep 12.

    Article  PubMed  Google Scholar 

  59. Nastri CO, Gibreel A, Raine-Fenning N, Maheshwari A, Ferriani RA, Bhattacharya S, Martins WP. Endometrial injury in women undergoing assisted reproductive techniques. Cochrane Database Syst Rev. 2012;7, CD009517. doi:10.1002/14651858.CD009517.pub2. Review.

    PubMed  Google Scholar 

  60. Nastri CO, Ferriani RA, Raine-Fenning N, Martins WP. Endometrial scratching performed in the non-transfer cycle and outcome of assisted reproduction: a randomized controlled trial. Ultrasound Obstet Gynecol. 2013;42(4):375–82. doi:10.1002/uog.12539. Epub 2013 Sep 2.

    CAS  PubMed  Google Scholar 

  61. Kumbak B, Sahin L, Ozkan S, Atilgan R. Impact of luteal phase hysteroscopy and concurrent endometrial biopsy on subsequent IVF cycle outcome. Arch Gynecol Obstet. 2014;290(2):369–74. Epub ahead of print.

    Article  PubMed  Google Scholar 

  62. Hayashi T, Kitaya K, Tada Y, Taguchi S, Funabiki M, Nakamura Y. Single curettage endometrial biopsy injury in the proliferative phase improves reproductive outcome of subsequent in vitro fertilization-embryo transfer cycle in infertile patients with repeated embryo implantation failure. Clin Exp Obstet Gynecol. 2013;40(3):323–6.

    CAS  PubMed  Google Scholar 

  63. Seshadri S, Sunkara SK, Khalaf Y, El-Toukhy T, Hamoda H. Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis. Reprod Biomed Online. 2012;25(6):572–84. doi:10.1016/j.rbmo.2012.08.007. Epub 2012 Sep 16. Review.

    Article  CAS  PubMed  Google Scholar 

  64. Fawzy M, El-Refaeey AA. Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure? Arch Gynecol Obstet. 2014;289(3):677–80. doi:10.1007/s00404-013-3020-8. Epub 2013 Sep 19.

    Article  CAS  PubMed  Google Scholar 

  65. Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akash H, Bdoor AN, Nawasreh M, Malkawi S, Diab F, Al-Ahmad N, Balawneh M, Abu-Salim A. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb). 2008;11(4):246–53. doi:10.1080/14647270801995431.

    Article  CAS  Google Scholar 

  66. Urman B, Ata B, Yakin K, Alatas C, Aksoy S, Mercan R, Balaban B. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod. 2009;24(7):1640–7. doi:10.1093/humrep/dep086. Epub 2009 Apr 8.

    Article  CAS  PubMed  Google Scholar 

  67. Berker B, Taşkin S, Kahraman K, Taşkin EA, Atabekoğlu C, Sönmezer M. The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study. Fertil Steril. 2011;95(8):2499–502. doi:10.1016/j.fertnstert.2010.12.033. Epub 2011 Jan 17.

    Article  CAS  PubMed  Google Scholar 

  68. Potdar N, Gelbaya TA, Konje JC, Nardo LG. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(6):674–84. doi:10.1093/humupd/dmt032. Epub 2013 Aug 2. Review.

    Article  CAS  PubMed  Google Scholar 

  69. Bernardi LA, Cohen RN, Stephenson MD. Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss. Fertil Steril. 2013;100(5):1326–31. doi:10.1016/j.fertnstert.2013.07.1975. Epub 2013 Aug 15.

    Article  CAS  PubMed  Google Scholar 

  70. Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2011;95(5):1650–4. doi:10.1016/j.fertnstert.2010.12.004. Epub 2010 Dec 30.

    Article  CAS  PubMed  Google Scholar 

  71. Chai J, Yeung WY, Lee CY, Li HW, Ho PC, Ng HY. Live birth rates following in vitro fertilization in women with thyroid autoimmunity and/or subclinical hypothyroidism. Clin Endocrinol (Oxf). 2014;80(1):122–7. doi:10.1111/cen.12220. Epub 2013 May 6.

    Article  CAS  Google Scholar 

  72. Absalan F, Ghannadi A, Kazerooni M, Parifar R, Jamalzadeh F, Amiri S. Value of sperm chromatin dispersion test in couples with unexplained recurrent abortion. J Assist Reprod Genet. 2012;29:11–4.

    Article  PubMed  Google Scholar 

  73. Brahem S, Mehdi M, Landolsi H, Mougou S, Elghezal H, Saad A. Semen parameters and sperm DNA fragmentation as causes of recurrent pregnancy loss. Urology. 2011;78:792–6.

    Article  PubMed  Google Scholar 

  74. Larson KL, DeJonge CJ, Barnes AM, Jost LK, Evenson DP. Sperm chromatin structure assay parameters as predictors of failed pregnancy following assisted reproductive techniques. Hum Reprod. 2000;15:1717–22.

    Article  CAS  PubMed  Google Scholar 

  75. Larson-Cook KL, Brannian JD, Hansen KA, Kasperson KM, Aamold ET, Evenson DP. Relationship between the outcomes of assisted reproductive techniques and sperm DNA fragmentation as measured by the sperm chromatin structure assay. Fertil Steril. 2003;80:895–902.

    Article  PubMed  Google Scholar 

  76. Bungum M, Humaidan P, Spano M, Jepson K, Bungum L, Giwercman A. The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod. 2004;19:1401–8.

    Article  CAS  PubMed  Google Scholar 

  77. Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J, Giwercman A. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod. 2007;22:174–9.

    Article  CAS  PubMed  Google Scholar 

  78. Gandini L, Lombardo F, Paoli D, Caruso F, Eleuteri P, Leter G, Ciriminna R, Culasso F, Dondero F, Lenzi A, Spano M. Full-term pregnancies achieved with ICSI despite high levels of sperm chromatin damage. Hum Reprod. 2004;19:1409–17.

    Article  CAS  PubMed  Google Scholar 

  79. Dar S, Grover SA, Moskovtsev SI, Swanson S, Baratz A, Librach CL. In vitro fertilization-intracytoplasmic sperm injection outcome in patients with a markedly high DNA fragmentation index (>50%). Fertil Steril. 2013;100(1):75–80. doi:10.1016/j.fertnstert.2013.03.011. Epub 2013 Apr 3.

    Article  PubMed  Google Scholar 

  80. Ni W, Xiao S, Qiu X, Jin J, Pan C, Li Y, Fei Q, Yang X, Zhang L, Huang X. Effect of sperm DNA fragmentation on clinical outcome of frozen-thawed embryo transfer and on blastocyst formation. PLoS One. 2014;9(4):e94956. doi:10.1371/journal.pone.0094956. eCollection 2014.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  81. Esteves SC, Oliveira FV, Bertolla RP. Clinical outcome of intracytoplasmic sperm injection in infertile men with treated and untreated clinical varicocele. J Urol. 2010;184(4):1442–6. doi:10.1016/j.juro.2010.06.004. Epub 2010 Aug 19.

    Article  PubMed  Google Scholar 

  82. Inci K, Hascicek M, Kara O, Dikmen AV, Gürgan T, Ergen A. Sperm retrieval and intracytoplasmic sperm injection in men with nonobstructive azoospermia, and treated and untreated varicocele. J Urol. 2009;182(4):1500–5. doi:10.1016/j.juro.2009.06.028. Epub 2009 Aug 15.

    Article  PubMed  Google Scholar 

  83. Stern C, Pertile M, Norris H, Hale L, Baker HW. Chromosome translocations in couples with in-vitro fertilization implantation failure. Hum Reprod. 1999;14:2097–101.

    Article  CAS  PubMed  Google Scholar 

  84. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340(8810):17–8.

    Article  CAS  PubMed  Google Scholar 

  85. Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril. 2012;98(6):1395–9. doi:10.1016/j.fertnstert.2012.08.026. Epub 2012 Sep 12.

    Article  Google Scholar 

  86. Johnson LN, Sasson IE, Sammel MD, Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil Steril. 2013;100(3):704–11. doi:10.1016/j.fertnstert.2013.04.038. Epub 2013 Jun 15. Review.

    Article  PubMed  Google Scholar 

  87. Kim JY, Kim JH, Jee BC, Lee JR, Suh CS, Kim SH. Can intracytoplasmic sperm injection prevent total fertilization failure and enhance embryo quality in patients with non-male factor infertility? Eur J Obstet Gynecol Reprod Biol. 2014;178:188–91. doi:10.1016/j.ejogrb.2014.03.044. Epub 2014 Apr 13.

    Article  PubMed  Google Scholar 

  88. Palermo GD, Neri QV, Takeuchi T, Rosenwaks Z. ICSI: where we have been and where we are going. Semin Reprod Med. 2009;27(2):191–201. doi:10.1055/s-0029-1202309. Epub 2009 Feb 26.

    Article  PubMed  Google Scholar 

  89. Palermo GD, Neri QV, Hariprashad JJ, Davis OK, Veeck LL, Rosenwaks Z. ICSI and its outcome. Semin Reprod Med. 2000;18(2):161–9.

    Article  CAS  PubMed  Google Scholar 

  90. Nagy ZP, Joris H, Liu J, Staessen C, Devroey P, Van Steirteghem AC. Intracytoplasmic single sperm injection of 1-day-old unfertilized human oocytes. Hum Reprod. 1993;8(12):2180–4.

    CAS  PubMed  Google Scholar 

  91. Mahutte NG, Arici A. Failed fertilization: is it predictable? Curr Opin Obstet Gynecol. 2003;15(3):211–8.

    Article  PubMed  Google Scholar 

  92. Rawe VY, Olmedo SB, Nodar FN, Doncel GD, Acosta AA, Vitullo AD. Cytoskeletal organization defects and abortive activation in human oocytes after IVF and ICSI failure. Mol Hum Reprod. 2000;6(6):510–6.

    Article  CAS  PubMed  Google Scholar 

  93. Huang B, Li Z, Zhu L, Hu D, Liu Q, Zhu G, Zhang H. Progesterone elevation on the day of HCG administration may affect rescue ICSI. Reprod Biomed Online. 2014;29(1):88–93. doi:10.1016/j.rbmo.2014.03.015. pii: S1472-6483(14)00182-5. Epub ahead of print.

    Article  CAS  PubMed  Google Scholar 

  94. Chen L, Xu Z, Zhang N, Wang B, Chen H, Wang S, Sun H. Neonatal outcome of early rescue ICSI and ICSI with ejaculated sperm. J Assist Reprod Genet. 2014;31(7):823–8. Epub ahead of print.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Bartoov B, Berkovitz A, Eltes F. Selection of spermatozoa with normal nuclei to improve the pregnancy rate with intracytoplasmic sperm injection. N Engl J Med. 2001;345(14):1067–8.

    Article  CAS  PubMed  Google Scholar 

  96. Garolla A, Fortini D, Menegazzo M, De Toni L, Nicoletti V, Moretti A, Selice R, Engl B, Foresta C. High-power microscopy for selecting spermatozoa for ICSI by physiological status. Reprod Biomed Online. 2008;17(5):610–6.

    Article  PubMed  Google Scholar 

  97. Leandri RD, Gachet A, Pfeffer J, Celebi C, Rives N, Carre-Pigeon F, Kulski O, Mitchell V, Parinaud J. Is intracytoplasmic morphologically selected sperm injection (IMSI) beneficial in the first ART cycle? A multicentric randomized controlled trial. Andrology. 2013;1(5):692–7. doi:10.1111/j.2047-2927.2013.00104.x. Epub 2013 Jun 21.

    Article  CAS  PubMed  Google Scholar 

  98. Boitrelle F, Guthauser B, Alter L, Bailly M, Bergere M, Wainer R, Vialard F, Albert M, Selva J. High-magnification selection of spermatozoa prior to oocyte injection: confirmed and potential indications. Reprod Biomed Online. 2014;28(1):6–13. doi:10.1016/j.rbmo.2013.09.019. Epub 2013 Sep 28.

    Article  CAS  PubMed  Google Scholar 

  99. Hammoud I, Boitrelle F, Ferfouri F, Vialard F, Bergere M, Wainer B, Bailly M, Albert M, Selva J. Selection of normal spermatozoa with a vacuole-free head (x6300) improves selection of spermatozoa with intact DNA in patients with high sperm DNA fragmentation rates. Andrologia. 2013;45(3):163–70. doi:10.1111/j.1439-0272.2012.01328.x. Epub 2012 Jun 26.

    Article  CAS  PubMed  Google Scholar 

  100. El Khattabi L, Dupont C, Sermondade N, Hugues JN, Poncelet C, Porcher R, Cedrin-Durnerin I, Lévy R, Sifer C. Is intracytoplasmic morphologically selected sperm injection effective in patients with infertility related to teratozoospermia or repeated implantation failure? Fertil Steril. 2013;100(1):62–8. doi:10.1016/j.fertnstert.2013.02.048. Epub 2013 Mar 30.

    Article  PubMed  Google Scholar 

  101. Lo Monte G, Murisier F, Piva I, Germond M, Marci R. Focus on intracytoplasmic morphologically selected sperm injection (IMSI): a mini-review. Asian J Androl. 2013;15(5):608–15. doi:10.1038/aja.2013.54. Epub 2013 Jul 8.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Setti AS, Paes de Almeida Ferreira Braga D, Iaconelli Jr A, Aoki T, Borges Jr E. Twelve years of MSOME and IMSI: a review. Reprod Biomed Online. 2013;27(4):338–52. doi:10.1016/j.rbmo.2013.06.011. Epub 2013 Jun 28. Review.

    Article  PubMed  Google Scholar 

  103. Parmegiani L, Cognigni GE, Bernardi S, Troilo E, Ciampaglia W, Filicori M. “Physiologic ICSI”: hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril. 2010;93(2):598–604. doi:10.1016/j.fertnstert.2009.03.033. Epub 2009 Apr 25.

    Article  PubMed  Google Scholar 

  104. Parmegiani L, Cognigni GE, Ciampaglia W, Pocognoli P, Marchi F, Filicori M. Efficiency of hyaluronic acid (HA) sperm selection. J Assist Reprod Genet. 2010;27(1):13–6. doi:10.1007/s10815-009-9380-0. Epub 2009 Dec 30.

    Article  PubMed  Google Scholar 

  105. Parmegiani L, Cognigni GE, Bernardi S, Troilo E, Taraborrelli S, Arnone A, Maccarini AM, Filicori M. Comparison of two ready-to-use systems designed for sperm-hyaluronic acid binding selection before intracytoplasmic sperm injection: PICSI vs. Sperm Slow: a prospective, randomized trial. Fertil Steril. 2012;98(3):632–7. doi:10.1016/j.fertnstert.2012.05.043. Epub 2012 Jun 29.

    Article  PubMed  Google Scholar 

  106. Majumdar G, Majumdar A. A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parameters. J Assist Reprod Genet. 2013;30(11):1471–5. doi:10.1007/s10815-013-0108-9. Epub 2013 Oct 2.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Worrilow KC, Eid S, Woodhouse D, Perloe M, Smith S, Witmyer J, Ivani K, Khoury C, Ball GD, Elliot T, Lieberman J. Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes—multicenter, double-blinded and randomized controlled trial. Hum Reprod. 2013;28(2):306–14. doi:10.1093/humrep/des417. Epub 2012 Nov 30.

    Article  CAS  PubMed  Google Scholar 

  108. Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org. Role of assisted hatching in in vitro fertilization: a guideline. Fertil Steril. 2014. pii: S0015-0282(14)00497-X. doi:10.1016/j.fertnstert.2014.05.034. [Epub ahead of print].

  109. Carney SK, Das S, Blake D, Farquhar C, Seif MM, Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). Cochrane Database Syst Rev. 2012;12, CD001894. doi:10.1002/14651858.CD001894.pub5. Review.

    PubMed  Google Scholar 

  110. Martins WP, Rocha IA, Ferriani RA, Nastri CO. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update. 2011;17(4):438–53. doi:10.1093/humupd/dmr012. Epub 2011 Apr 7. Review. Erratum in: Hum Reprod Update. 2012;18(5):600.

    Google Scholar 

  111. Carson DD, Dutt A, Tang JP. Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol. 1987;120(1):228–35.

    Article  CAS  PubMed  Google Scholar 

  112. Schoolcraft W, Lane M, Stevens J, Gardner DK. Increased hyaluronan concentration in the embryo transfer medium results in a significant increase in human embryo implantation rate. Fertil Steril. 2002;76 Suppl 3:S5.

    Article  Google Scholar 

  113. Valojerdi MR, Karimian L, Yazdi PE, Gilani MA, Madani T, Baghestani AR. Efficacy of a human embryo transfer medium: a prospective, randomized clinical trial study. J Assist Reprod Genet. 2006;23(5):207–12. Epub 2006 Jun 20.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Wu F, Lü R, Bai XH, Song XR. Influence of EmbryoGlue on the implantation of embryo and pregnancy outcome in vitro fertilization-embryo transfer [article in Chinese]. Zhonghua Fu Chan Ke Za Zhi. 2012;47(2):121–4.

    PubMed  Google Scholar 

  115. Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Database Syst Rev. 2014;2, CD007421. doi:10.1002/14651858.CD007421.pub3.

    PubMed  Google Scholar 

  116. Gardner DK, Lane M, Schoolcraft WB. Culture and transfer of viable blastocysts: a feasible proposition for human IVF. Hum Reprod. 2000;15 Suppl 6:9–23.

    PubMed  Google Scholar 

  117. Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB. Single blastocyst transfer: a prospective randomized trial. Fertil Steril. 2004;81(3):551–5.

    Article  CAS  PubMed  Google Scholar 

  118. Papanikolaou EG, Kolibianakis EM, Tournaye H, Venetis CA, Fatemi H, Tarlatzis B, Devroey P. Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod. 2008;23(1):91–9. Epub 2007 Oct 26. Review.

    Article  PubMed  Google Scholar 

  119. Sepúlveda SJ, Portella JR, Noriega LP, Escudero EL, Noriega LH. Extended culture up to the blastocyst stage: a strategy to avoid multiple pregnancies in assisted reproductive technologies. Biol Res. 2011;44(2):195–9. doi:/S0716-97602011000200012. Epub 2011 Sep 20.

    Article  PubMed  Google Scholar 

  120. Blake DA, Farquhar CM, Johnson N, Proctor M. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev. 2007 17;(4):CD002118. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002118

  121. Thomas MR, Sparks AE, Ryan GL, Van Voorhis BJ. Clinical predictors of human blastocyst formation and pregnancy after extended embryo culture and transfer. Fertil Steril. 2010;94(2):543–8. doi:10.1016/j.fertnstert.2009.03.051. Epub 2009 May 5.

    Article  PubMed  Google Scholar 

  122. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2012;7, CD002118. doi:10.1002/14651858.CD002118.pub4. Review.

    PubMed  Google Scholar 

  123. Wang SS, Sun HX. Blastocyst transfer ameliorates live birth rate compared with cleavage-stage embryos transfer in fresh in vitro fertilization or intracytoplasmic sperm injection cycles: reviews and meta-analysis. Yonsei Med J. 2014;55(3):815–25. doi:10.3349/ymj.2014.55.3.815. Epub 2014 Apr 1.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Mesut N, Ciray HN, Mesut A, Aksoy T, Bahceci M. Cryopreservation of blastocysts is the most feasible strategy in good responder patients. Fertil Steril. 2011;96(5):1121–5.e1. doi:10.1016/j.fertnstert.2011.08.012. Epub 2011 Sep 3.

    Article  PubMed  Google Scholar 

  125. Zhu L, Xi Q, Zhang H, Li Y, Ai J, Jin L. Blastocyst culture and cryopreservation to optimize clinical outcomes of warming cycles. Reprod Biomed Online. 2013;27(2):154–60. doi:10.1016/j.rbmo.2013.04.006. Epub 2013 Apr 19.

    Article  PubMed  Google Scholar 

  126. Scott Jr RT, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100(3):624–30. doi:10.1016/j.fertnstert.2013.04.039. Epub 2013 Jun 15.

    Article  PubMed  Google Scholar 

  127. Scott KL, Hong KH, Scott Jr RT. Selecting the optimal time to perform biopsy for preimplantation genetic testing. Fertil Steril. 2013;100(3):608–14. doi:10.1016/j.fertnstert.2013.07.004. Review.

    Article  PubMed  Google Scholar 

  128. Ly KD, Agarwal A, Nagy ZP. Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? J Assist Reprod Genet. 2011;28(9):833–49. doi:10.1007/s10815-011-9608-7. Epub 2011 Jul 9.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De los Santos MJ, Giles J, Labarta E, Domingo J, Crespo J, Remohí J, Pellicer A, Simón C. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril. 2013;99(5):1400–7. doi:10.1016/j.fertnstert.2012.11.041. Epub 2012 Dec 20.

    Article  PubMed  Google Scholar 

  130. Blockeel C, Schutyser V, De Vos A, Verpoest W, De Vos M, Staessen C, Haentjens P, Van der Elst J, Devroey P. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online. 2008;17(6):848–54.

    Article  PubMed  Google Scholar 

  131. Yakin K, Ata B, Ercelen N, Balaban B, Urman B. The effect of preimplantation genetic screening on the probability of live birth in young women with recurrent implantation failure; a nonrandomized parallel group trial. Eur J Obstet Gynecol Reprod Biol. 2008;140(2):224–9. doi:10.1016/j.ejogrb.2008.05.005. Epub 2008 Jul 7.

    Article  PubMed  Google Scholar 

  132. Scott Jr RT, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril. 2013;100(3):697–703. doi:10.1016/j.fertnstert.2013.04.035. Epub 2013 Jun 1.

    Article  PubMed  Google Scholar 

  133. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol. 2014;12:22. doi:10.1186/1477-7827-12-22.

    Article  PubMed  PubMed Central  Google Scholar 

  134. van Loendersloot L, van Wely M, Goddijn M, Repping S, Bossuyt P, van der Veen F. Pregnancy and twinning rates using a tailored embryo transfer policy. Reprod Biomed Online. 2013;26(5):462–9. doi:10.1016/j.rbmo.2013.01.010. Epub 2013 Jan 26.

    Article  PubMed  Google Scholar 

  135. Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Criteria for number of embryos to transfer: a committee opinion. Fertil Steril. 2013;99(1):44–6. doi:10.1016/j.fertnstert.2012.09.038. Epub 2012 Oct 22.

    Article  Google Scholar 

  136. Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane Database Syst Rev. 2013;7, CD003416. doi:10.1002/14651858.CD003416.pub4. Review.

    PubMed  Google Scholar 

  137. Barritt J, Willadsen S, Brenner C, Cohen J. Cytoplasmic transfer in assisted reproduction. Hum Reprod Update. 2001;7(4):428–35. Review.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Austin Fertility and Reproductive Medicine/Westlake IVF, 300 Beardsley Lane, Bldg B, Suite 200, Austin, TX, 78746, USA

    Shahryar K. Kavoussi MD, MPH & Thomas B. Pool PhD, HCLD

  2. Fertility Center of San Antonio, 4499 Medical Drive, Suite 200, San Antonio, TX, 78229, USA

    Thomas B. Pool PhD, HCLD

Authors
  1. Shahryar K. Kavoussi MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas B. Pool PhD, HCLD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahryar K. Kavoussi MD, MPH .

Editor information

Editors and Affiliations

  1. School of Medicine, University of Sydney, Sydney, New South Wales, Australia

    Steven D. Fleming

  2. ASTRA Fertility Group, Mississauga, Ontario, Canada

    Alex C. Varghese

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kavoussi, S.K., Pool, T.B. (2016). Optimization of Treatment Outcomes for Assisted Reproductive Technologies. In: Fleming, S., Varghese, A. (eds) Organization and Management of IVF Units. Springer, Cham. https://doi.org/10.1007/978-3-319-29373-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29373-8_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29371-4

  • Online ISBN: 978-3-319-29373-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation